ELOS
COM:ELOSMEDTECH
Elos Medtech
- Stock
Last Close
200.00
19/12 16:29
Market Cap
1.64B
Beta: -
Volume Today
10.32K
Avg: -
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '13 | Dec '14 | Dec '15 | Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
average inventory | 117.24M - | 113.86M 2.89% | 121.07M 6.34% | 130.74M 7.98% | 136.97M 4.77% | 153.99M 12.42% | 170.02M 10.41% | 166.34M 2.16% | 165.31M 0.62% | 201.44M 21.86% | |
average payables | 18.98M - | 20.47M 7.86% | 21.78M 6.40% | 21.08M 3.22% | 25.88M 22.80% | 32.68M 26.24% | 27.82M 14.86% | 28.67M 3.06% | 38.24M 33.38% | 42.41M 10.91% | |
average receivables | 43.06M - | 43.06M 0% | 109.41M - | ||||||||
book value per share | 34.99 - | 50.89 45.42% | 49.68 2.37% | 55.13 10.96% | 60.98 10.61% | 66.92 9.75% | 66.92 0.00% | 66.97 0.07% | 78.64 17.42% | 98.97 25.86% | |
capex per share | -3.20 - | -3.59 12.21% | -6.95 93.80% | -5.20 25.24% | -6.21 19.48% | -10.52 69.33% | -12.22 16.20% | -7.01 42.66% | -10.60 51.35% | -14.53 37.02% | |
capex to depreciation | -0.52 - | -0.69 31.09% | -0.95 37.96% | -0.63 33.25% | -0.73 15.72% | -1.42 93.20% | -1.64 15.53% | -0.94 42.42% | -1.54 63.75% | -1.82 17.94% | |
capex to operating cash flow | -0.24 - | -0.43 77.26% | -0.75 73.82% | -0.35 53.14% | -0.61 71.96% | -1.21 99.93% | -0.96 20.46% | -0.45 53.22% | -0.82 81.03% | -1.08 32.84% | |
capex to revenue | -0.04 - | -0.06 41.26% | -0.09 46.54% | -0.06 31.78% | -0.07 3.77% | -0.12 90.60% | -0.14 15.39% | -0.10 31.84% | -0.12 21.32% | -0.13 11.58% | |
cash per share | 4.31 - | -16.12 474.28% | -47.66 195.60% | 5.78 112.14% | 1.59 72.52% | 6.44 305.35% | 6.84 6.11% | 10.96 60.32% | 11.79 7.55% | 20.91 77.36% | |
days of inventory on hand | 131.98 - | 149.79 13.49% | 129.14 13.79% | 121.51 5.90% | 125.19 3.03% | 129.54 3.47% | 133.85 3.33% | 147.17 9.95% | 134.51 8.60% | 145.46 8.14% | |
days payables outstanding | 22.06 - | 28.88 30.95% | 21.79 24.56% | 18.69 14.23% | 27.72 48.31% | 26.46 4.55% | 16.75 36.71% | 33.04 97.32% | 31.95 3.30% | 27.68 13.36% | |
days sales outstanding | 54.39 - | 50.21 - | |||||||||
debt to assets | 0.32 - | 0.26 19.56% | 0.37 42.09% | 0.40 7.79% | 0.39 1.34% | 0.30 22.05% | 0.32 3.91% | 0.27 13.84% | 0.25 6.77% | 0.25 0.14% | |
debt to equity | 0.73 - | 0.46 36.63% | 0.98 111.15% | 0.96 2.20% | 0.90 6.35% | 0.57 36.11% | 0.61 5.79% | 0.51 16.63% | 0.45 10.75% | 0.45 0.51% | |
dividend yield | 0.02 - | 0.03 75.00% | 0.02 17.41% | 0.01 58.21% | 0.02 110.17% | 0.01 - | 0.01 - | ||||
earnings yield | 0.09 - | 0.28 213.07% | 0.02 92.41% | 0.04 106.00% | 0.06 38.26% | 0.04 35.62% | 0.04 13.50% | 0.04 7.72% | 0.03 17.31% | 0.04 10.59% | |
enterprise value | 499.43M - | 443.14M 11.27% | 1.03B 132.63% | 909.23M 11.80% | 690.33M 24.07% | 773.07M 11.99% | 1.13B 46.39% | 1.06B 6.67% | 2.40B 127.40% | 1.82B 24.40% | |
enterprise value over ebitda | 5.59 - | 6.12 9.54% | 13.03 112.66% | 8.99 30.95% | 7.96 11.45% | 8.07 1.35% | 9.02 11.78% | 8.96 0.65% | 15.14 68.89% | 10.20 32.65% | |
ev to operating cash flow | 5.72 - | 8.02 40.16% | 16.73 108.64% | 9.25 44.71% | 11.12 20.17% | 11.71 5.30% | 11.05 5.63% | 8.41 23.85% | 22.88 172.00% | 16.77 26.70% | |
ev to sales | 1.04 - | 1.16 11.70% | 2.05 75.91% | 1.65 19.52% | 1.19 27.48% | 1.20 0.38% | 1.64 36.90% | 1.82 10.94% | 3.32 82.28% | 2.04 38.43% | |
free cash flow per share | 9.92 - | 4.72 52.46% | 2.31 51.11% | 9.57 315.13% | 4.05 57.66% | -1.82 145.00% | 0.48 126.22% | 8.56 1,689.27% | 2.41 71.87% | -1.11 146.11% | |
free cash flow yield | 0.18 - | 0.08 58.40% | 0.02 73.08% | 0.11 420.49% | 0.07 37.76% | -0.03 139.28% | 0.00 117.18% | 0.08 1,664.42% | 0.01 88.91% | -0.00 151.36% | |
graham net net | -31.72 - | -48.13 51.71% | -120.69 150.76% | -62.61 48.12% | -55.05 12.07% | -41.73 24.19% | -43.69 4.68% | -36.47 16.53% | -38.50 5.56% | -30.84 19.88% | |
graham number | 62.14 - | 141.74 128.10% | 51.99 63.32% | 70.19 35.02% | 71.59 1.99% | 64.41 10.03% | 84.77 31.60% | 82.03 3.23% | 128.75 56.95% | 143.92 11.79% | |
income quality | 2.10 - | 1.74 17.13% | 2.73 57.42% | 2.59 5.24% | 2.35 9.25% | 2.32 1.39% | 2.02 12.72% | 2.90 43.39% | 1.07 63.10% | 1.44 34.72% | |
intangibles to total assets | 0.15 - | 0.11 26.27% | 0.31 177.60% | 0.33 4.42% | 0.32 3.55% | 0.29 7.66% | 0.27 5.85% | 0.25 7.53% | 0.24 4.52% | 0.21 13.78% | |
interest coverage | 6.71 - | 5.84 13.02% | 3.82 34.60% | 4.30 12.55% | 4.60 7.10% | 3.70 19.68% | 5.25 42.09% | 5.82 10.74% | 9.88 69.79% | ||
interest debt per share | 26.71 - | 24.48 8.36% | 49.90 103.87% | 54.34 8.91% | 56.29 3.57% | 39.78 29.33% | 42.15 5.98% | 35.24 16.40% | 36.78 4.37% | 44.92 22.13% | |
inventory turnover | 2.77 - | 2.44 11.89% | 2.83 15.99% | 3.00 6.27% | 2.92 2.94% | 2.82 3.36% | 2.73 3.22% | 2.48 9.05% | 2.71 9.41% | 2.51 7.53% | |
invested capital | 0.73 - | 0.46 36.63% | 0.98 111.15% | 0.96 2.20% | 0.90 6.35% | 0.57 36.11% | 0.61 5.79% | 0.51 16.63% | 0.45 10.75% | 0.45 0.51% | |
market cap | 360.03M - | 411.47M 14.29% | 747.30M 81.62% | 596.02M 20.24% | 368.65M 38.15% | 530.34M 43.86% | 859.24M 62.02% | 871.34M 1.41% | 2.21B 153.70% | 1.98B 10.22% | |
net current asset value | -71.16M - | 34.19M 148.05% | -306.33M 995.92% | -282.50M 7.78% | -240.32M 14.93% | -146.38M 39.09% | -189.47M 29.44% | -127.05M 32.94% | -108.88M 14.30% | -73.62M 32.39% | |
net debt to ebitda | 1.56 - | 0.44 71.95% | 3.58 718.47% | 3.10 13.52% | 3.71 19.78% | 2.53 31.71% | 2.17 14.28% | 1.57 27.76% | 1.21 23.15% | -0.95 178.54% | |
net income per share | 4.90 - | 17.55 257.79% | 2.42 86.22% | 3.97 64.30% | 3.74 5.96% | 2.76 26.24% | 4.77 73.18% | 4.47 6.42% | 9.37 109.79% | 9.30 0.71% | |
operating cash flow per share | 13.12 - | 8.30 36.69% | 9.26 11.49% | 14.77 59.54% | 10.26 30.52% | 8.69 15.31% | 12.70 46.08% | 15.56 22.57% | 13.01 16.39% | 13.42 3.15% | |
payables turnover | 16.55 - | 12.64 23.63% | 16.75 32.56% | 19.53 16.59% | 13.17 32.58% | 13.80 4.76% | 21.80 57.99% | 11.05 49.32% | 11.42 3.41% | 13.18 15.42% | |
receivables turnover | 6.71 - | 7.27 - | |||||||||
research and ddevelopement to revenue | 0.05 - | 0.03 46.42% | 0.03 6.51% | 0.03 0.59% | 0.02 13.97% | 0.03 25.07% | 0.02 16.49% | 0.03 7.63% | 0.02 9.09% | 0.03 12.63% | |
return on tangible assets | 0.07 - | 0.22 198.18% | 0.03 87.74% | 0.04 66.52% | 0.04 11.95% | 0.03 20.79% | 0.05 66.13% | 0.05 6.02% | 0.09 83.81% | 0.07 24.71% | |
revenue per share | 72.05 - | 57.23 20.56% | 75.69 32.24% | 82.95 9.60% | 95.51 15.14% | 84.85 11.16% | 85.45 0.70% | 71.89 15.87% | 89.69 24.76% | 110.13 22.80% | |
roe | 0.14 - | 0.34 146.04% | 0.05 85.89% | 0.07 48.06% | 0.06 14.98% | 0.04 32.79% | 0.07 73.19% | 0.07 6.48% | 0.12 78.66% | 0.09 21.11% | |
roic | 0.09 - | 0.05 46.90% | 0.03 32.27% | 0.04 25.23% | 0.05 27.29% | 0.03 31.43% | 0.05 57.21% | 0.06 15.02% | 0.08 32.03% | 0.08 3.33% | |
sales general and administrative to revenue | 0.11 - | 0.12 5.01% | 0.13 8.53% | 0.12 6.26% | 0.12 0.04% | 0.13 6.17% | 0.14 8.30% | 0.14 2.12% | 0.14 3.07% | 0.13 6.59% | |
shareholders equity per share | 34.99 - | 50.89 45.42% | 49.68 2.37% | 55.13 10.96% | 60.98 10.61% | 66.92 9.75% | 66.92 0.00% | 66.97 0.07% | 78.64 17.42% | 98.97 25.86% | |
stock based compensation to revenue | |||||||||||
tangible asset value | 151.80M - | 270.15M 77.97% | 54.85M 79.70% | 76.93M 40.25% | 102.01M 32.60% | 230.03M 125.50% | 256.51M 11.51% | 286.54M 11.71% | 362.08M 26.36% | 501.86M 38.60% | |
tangible book value per share | 22.81 - | 40.60 77.97% | 8.24 79.70% | 11.56 40.25% | 16.86 45.83% | 30.28 79.59% | 31.79 5.02% | 35.52 11.71% | 44.88 26.36% | 62.20 38.60% | |
working capital | 96.02M - | 196.85M 105.01% | 24.89M 87.36% | -309K 101.24% | 33.15M 10,826.86% | 147.68M 345.54% | 167.21M 13.23% | 178.29M 6.62% | 207.73M 16.52% | 395.38M 90.33% |
All numbers in (except ratios and percentages)